Follow
Charles Day
Charles Day
Graduate Student, Vanderbilt University
Verified email at vanderbilt.edu
Title
Cited by
Cited by
Year
Simplified equation to extract diffusion coefficients from confocal FRAP data
M Kang, CA Day, AK Kenworthy, E DiBenedetto
Traffic 13 (12), 1589-1600, 2012
2662012
Active metabolite of atorvastatin inhibits membrane cholesterol domain formation by an antioxidant mechanism
RP Mason, MF Walter, CA Day, RF Jacob
Journal of biological chemistry 281 (14), 9337-9345, 2006
2142006
Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions
RP Mason, MF Walter, CA Day, RF Jacob
The American journal of cardiology 96 (5), 11-23, 2005
1982005
Synergistic effect of amlodipine and atorvastatin in reversing LDL-induced endothelial dysfunction
RP Mason, R Kubant, G Heeba, RF Jacob, CA Day, YS Medlin, ...
Pharmaceutical research 25, 1798-1806, 2008
1692008
Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDs
MF Walter, RF Jacob, CA Day, R Dahlborg, Y Weng, RP Mason
Atherosclerosis 177 (2), 235-243, 2004
1532004
Tracking microdomain dynamics in cell membranes
CA Day, AK Kenworthy
Biochimica et Biophysica Acta (BBA)-Biomembranes 1788 (1), 245-253, 2009
1482009
A generalization of theory for two-dimensional fluorescence recovery after photobleaching applicable to confocal laser scanning microscopes
M Kang, CA Day, K Drake, AK Kenworthy, E DiBenedetto
Biophysical journal 97 (5), 1501-1511, 2009
1162009
Analysis of protein and lipid dynamics using confocal fluorescence recovery after photobleaching (FRAP)
CA Day, LJ Kraft, M Kang, AK Kenworthy
Current protocols in cytometry 62 (1), 2.19. 1-2.19. 29, 2012
1092012
Rofecoxib increases susceptibility of human LDL and membrane lipids to oxidative damage: a mechanism of cardiotoxicity
RP Mason, MF Walter, HP McNulty, SF Lockwood, J Byun, CA Day, ...
Journal of Cardiovascular Pharmacology 47, S7-S14, 2006
1052006
Intermolecular differences for HMG-CoA reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions
RP Mason, MF Walter, CA Day, RF Jacob
Am. J Cardiol 96 (5A), 11F-23F, 2005
992005
Chromosome missegregation during anaphase triggers p53 cell cycle arrest through histone H3. 3 Ser31 phosphorylation
EH Hinchcliffe, CA Day, KB Karanjeet, S Fadness, A Langfald, ...
Nature cell biology 18 (6), 668-675, 2016
922016
Functions of cholera toxin B-subunit as a raft cross-linker
CA Day, AK Kenworthy
Essays in biochemistry 57, 135-145, 2015
792015
A quantitative approach to analyze binding diffusion kinetics by confocal FRAP
M Kang, CA Day, E DiBenedetto, AK Kenworthy
Biophysical journal 99 (9), 2737-2747, 2010
782010
Mechanisms underlying the confined diffusion of cholera toxin B-subunit in intact cell membranes
CA Day, AK Kenworthy
PloS one 7 (4), e34923, 2012
632012
Microtubule Motors Power Plasma Membrane Tubulation in Clathrin‐Independent Endocytosis
CA Day, NW Baetz, CA Copeland, LJ Kraft, B Han, A Tiwari, KR Drake, ...
Traffic 16 (6), 572-590, 2015
622015
Lysosomal degradation ensures accurate chromosomal segregation to prevent chromosomal instability
E Almacellas, J Pelletier, C Day, S Ambrosio, A Tauler, C Mauvezin
Autophagy 17 (3), 796-813, 2021
352021
A biological rationale for the cardiotoxic effects of rofecoxib: comparative analysis with other COX-2 selective agents and NSAids
RP Mason, MF Walter, CA Day, RF Jacob
Inflammation in the Pathogenesis of Chronic Diseases: The COX-2 Controversy …, 2007
342007
Topologically diverse human membrane proteins partition to liquid-disordered domains in phase-separated lipid vesicles
JP Schlebach, PJ Barrett, CA Day, JH Kim, AK Kenworthy, CR Sanders
Biochemistry 55 (7), 985-988, 2016
232016
Engineered disulfide bond greatly increases specific activity of recombinant murine interferon-β
C DAY, B SCHWARTZ, BL Li, S PESTKA
Journal of interferon research 12 (2), 139-143, 1992
211992
Increased susceptibility of Pseudomonas aeruginosa to ciprofloxacin in the presence of vancomycin
CA Day, ML Marceau-Day, DF Day
Antimicrobial agents and chemotherapy 37 (11), 2506-2508, 1993
191993
The system can't perform the operation now. Try again later.
Articles 1–20